Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Intangibles (2020 - 2022)

Journey Medical (DERM) has disclosed Change in Intangibles for 3 consecutive years, with $20.0 million as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Change in Intangibles changed N/A year-over-year to $20.0 million, compared with a TTM value of $21.2 million through Sep 2022, changed N/A, and an annual FY2021 reading of $10.0 million, up 733.33% over the prior year.
  • Change in Intangibles was $20.0 million for Q1 2022 at Journey Medical, up from $1.2 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $20.0 million in Q1 2022 and bottomed at $200000.0 in Q4 2020.
  • Average Change in Intangibles over 3 years is $7.1 million, with a median of $1.2 million recorded in 2021.
  • Peak annual rise in Change in Intangibles hit 500.0% in 2021, while the deepest fall reached 500.0% in 2021.
  • Year by year, Change in Intangibles stood at $200000.0 in 2020, then surged by 500.0% to $1.2 million in 2021, then skyrocketed by 1566.67% to $20.0 million in 2022.
  • Business Quant data shows Change in Intangibles for DERM at $20.0 million in Q1 2022, $1.2 million in Q4 2021, and $200000.0 in Q4 2020.